Financials
Financial year 2025
Dr. Mellaerts from Tielt-Winge, company number BE0879069527, closed financial year 2025 with a result of € 336,321 after tax. For that financial year Dr. Mellaerts recorded a gross margin of € 473,761 and equity of € 1.3 million. Compared with financial year 2024, the result moved from € 325,595 to € 336,321. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
€ 1.3 million
▲ 20% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 336,321
▲ 3% vs 2024
Profit after tax over the fiscal year.
€ 240,264
▼ 9% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 120,545 paid out
36 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 40,096
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 142
▼ 75% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,000
▼ 56% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 340,484 | € 335,206 | € 460,215 | € 473,761 | ▲ 3% |
| Profit after taxes | € 219,804 | € 231,528 | € 325,595 | € 336,321 | ▲ 3% |
| Equity | € 686,655 | € 733,401 | € 1,058,996 | € 1,274,772 | ▲ 20% |
| Total debts | € 46,283 | € 226,272 | € 53,160 | € 46,575 | ▼ 12% |
| Cash | € 377,543 | € 112,047 | € 262,657 | € 240,264 | ▼ 9% |
| Retained profit | € 668,055 | € 714,801 | € 1,040,396 | € 1,256,172 | ▲ 21% |
| Dividend | € 0 | € 184,782 | € 0 | € 120,545 | |
| Balance sheet total | € 732,938 | € 959,672 | € 1,112,157 | € 1,321,347 | ▲ 19% |
Key figures of Dr. Mellaerts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Mellaerts the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Mellaerts?
What happened at Dr. Mellaerts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 336,321 (▲ 3% vs 2024). Source: NBB ↗
- Capital increase of € 150,300, published in the Gazette. Source: Staatsblad ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Tielt-Winge. KBO
In short
From € 219,804 profit in 2022 to € 336,321 profit in 2025.
Paid € 517,801 in corporate taxes since 2022.
Best year ever: 2025, with € 336,321 profit.
Paid out € 305,327 in dividends to the owners in total.
Management
Behind Dr. Mellaerts is Beatrice Mellaerts.
Directors
According to the 2025 annual accounts
Beatrice Mellaerts
Andere functie
Establishments
Establishment units
Physical locations of this company
Heuvelstraat 229
3390 Tielt-Winge
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- MELLAERTS Beatrice(oprichter) 100%
Details
- Company number
- 0879.069.527
- VAT number
- BE 0879.069.527
- Registered office
- Heuvelstraat 229, 3390 Tielt-Winge
- Names & denominations
- Dr. Mellaerts
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 January 2006
- Peppol
- Active · Active since 11 Nov 2024